Archivio pubblicazioni scientifiche
2012
December
April
2012
hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study1
Translational OncologyVolume 5, n.2: 105–112
2011
July
May
2010
December
2008
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients,,
British Journal of Cancer 101: 715-721
2010
Large Randomized Study of Thymosin 1, Interferon Alfa, or Both …,,
J Clin Oncol 28: 1780-1787
January
2009
September
July
2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
British Journal of Cancer 101: 715 – 721
January
2009
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments
Cancer Immunol Immunother 58:1297–1306


